PMID- 38089538
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231213
IS  - 2326-3253 (Print)
IS  - 2326-3253 (Electronic)
IS  - 2326-3253 (Linking)
VI  - 10
IP  - 12
DP  - 2023 Dec
TI  - Elevated Liver Enzymes With Positive Hepatitis B Serology After Intravenous 
      Immunoglobulin Treatment of Guillain-Barre Syndrome.
PG  - e01207
LID - 10.14309/crj.0000000000001207 [doi]
LID - e01207
AB  - Intravenous immunoglobulin (IVIG) is used to treat multiple conditions, one of 
      which is Guillain-Barre syndrome. Despite its multiple benefits, IVIG can cause a 
      wide variety of side effects, most of which resolve with supportive care. We 
      present a case in which a patient with new-onset Guillain-Barre syndrome was 
      treated with IVIG and subsequently developed an acute elevation in liver enzymes 
      with positive hepatitis B serology.
CI  - (c) 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The 
      American College of Gastroenterology.
FAU - Patel, Shivam
AU  - Patel S
AD  - Texas A&M University School of Medicine, Bryan, TX.
FAU - Le, Kim Minh Ngoc
AU  - Le KMN
AD  - Department of Gastroenterology, Baylor Scott & White Medical Center Round Rock, 
      Round Rock, TX.
FAU - Puskoor, Sujith
AU  - Puskoor S
AD  - Department of Internal Medicine, Baylor Scott & White Medical Center Round Rock, 
      Round Rock, TX.
FAU - Amaning, Judith
AU  - Amaning J
AD  - Department of Gastroenterology, Baylor Scott & White Medical Center Round Rock, 
      Round Rock, TX.
LA  - eng
PT  - Case Reports
DEP - 20231209
PL  - United States
TA  - ACG Case Rep J
JT  - ACG case reports journal
JID - 101638398
PMC - PMC10713141
OTO - NOTNLM
OT  - Guillain-Barre syndrome
OT  - IVIG
OT  - hepatitis B serology
OT  - liver enzyme elevation
EDAT- 2023/12/13 18:42
MHDA- 2023/12/13 18:43
PMCR- 2023/12/09
CRDT- 2023/12/13 12:52
PHST- 2023/06/20 00:00 [received]
PHST- 2023/10/17 00:00 [accepted]
PHST- 2023/12/13 18:43 [medline]
PHST- 2023/12/13 18:42 [pubmed]
PHST- 2023/12/13 12:52 [entrez]
PHST- 2023/12/09 00:00 [pmc-release]
AID - ACGCR-23-0500 [pii]
AID - 10.14309/crj.0000000000001207 [doi]
PST - epublish
SO  - ACG Case Rep J. 2023 Dec 9;10(12):e01207. doi: 10.14309/crj.0000000000001207. 
      eCollection 2023 Dec.